| Product NDC: | 17478-419 |
| Proprietary Name: | Chlorothiazide Sodium |
| Non Proprietary Name: | Chlorothiazide Sodium |
| Active Ingredient(s): | 500 mg/1 & nbsp; Chlorothiazide Sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17478-419 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011145 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20120813 |
| Package NDC: | 17478-419-40 |
| Package Description: | 1 VIAL in 1 CARTON (17478-419-40) > 1 INJECTION in 1 VIAL |
| NDC Code | 17478-419-40 |
| Proprietary Name | Chlorothiazide Sodium |
| Package Description | 1 VIAL in 1 CARTON (17478-419-40) > 1 INJECTION in 1 VIAL |
| Product NDC | 17478-419 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chlorothiazide Sodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120813 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Akorn, Inc. |
| Substance Name | CHLOROTHIAZIDE SODIUM |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |